Evidence map›Paper›PMID 27459965›Full record

ArticleBMC veterinary research2016

Sarcoptic mange in the Scandinavian wolf Canis lupus population.

Boris Fuchs, Barbara Zimmermann, Petter Wabakken, Set Bornstein, Johan Månsson, Alina L Evans, Olof Liberg, Håkan Sand, Jonas Kindberg, Erik O Ågren and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. FatalJournal of veterinary research · 2024
    Article
  2. Article
  3. Article
  4. A review of sarcoptic mange in North American wildlife.International journal for parasitology. Parasites and wildlife · 2019
    Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Boris FuchsFaculty of Applied Ecology and Agricultural Sciences, Hedmark University College, Campus Evenstad, N-2480, Koppang, Norway. boris.fuchs@hihm.no.ORCID http://orcid.org/0000-0003-3412-3490
Barbara ZimmermannFaculty of Applied Ecology and Agricultural Sciences, Hedmark University College, Campus Evenstad, N-2480, Koppang, Norway.
Petter WabakkenFaculty of Applied Ecology and Agricultural Sciences, Hedmark University College, Campus Evenstad, N-2480, Koppang, Norway.
Set BornsteinDepartment of Virology, Immunobiology and Parasitology, National Veterinary Institute, SE-75189, Uppsala, Sweden.
Johan MånssonDepartment of Ecology, Grimsö Wildlife Research Station, Swedish University of Agricultural Sciences, SE-73091, Riddarhyttan, Sweden.
Alina L EvansFaculty of Applied Ecology and Agricultural Sciences, Hedmark University College, Campus Evenstad, N-2480, Koppang, Norway.
Olof LibergDepartment of Ecology, Grimsö Wildlife Research Station, Swedish University of Agricultural Sciences, SE-73091, Riddarhyttan, Sweden.
Håkan SandDepartment of Ecology, Grimsö Wildlife Research Station, Swedish University of Agricultural Sciences, SE-73091, Riddarhyttan, Sweden.
Jonas KindbergDepartment of Wildlife, Fish and Environmental Studies, Swedish University of Agricultural Sciences, SE-90183, Umeå, Sweden.
Erik O ÅgrenDepartment of Pathology and Wildlife Disease, National Veterinary Institute, SE-75189, Uppsala, Sweden.
Jon M ArnemoFaculty of Applied Ecology and Agricultural Sciences, Hedmark University College, Campus Evenstad, N-2480, Koppang, Norway.
Swedish University of Agricultural Sciences · SESwedish Veterinary Agency · SEFugro (Norway) · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcoptic mange, a parasitic disease caused by the mite Sarcoptes scabiei, is regularly reported on wolves Canis lupus in Scandinavia. We describe the distribution and transmission of this parasite within the small but recovering wolf population by analysing 269 necropsy reports and performing a serological survey on 198 serum samples collected from free-ranging wolves between 1998 and 2013.

resultsThe serological survey among 145 individual captured Scandinavian wolves (53 recaptures) shows a consistent presence of antibodies against sarcoptic mange. Seropositivity among all captured wolves was 10.1 % (CI. 6.4 %-15.1 %). Sarcoptic mange-related mortality reported at necropsy was 5.6 % and due to secondary causes, predominantly starvation. In the southern range of the population, seroprevalence was higher, consistent with higher red fox densities. Female wolves had a lower probability of being seropositive than males, but for both sexes the probability increased with pack size. Recaptured individuals changing from seropositive to seronegative suggest recovery from sarcoptic mange. The lack of seropositive pups (8-10 months, N = 56) and the occurrence of seropositive and seronegative individuals in the same pack indicates interspecific transmission of S. scabiei into this wolf population.

conclusionsWe consider sarcoptic mange to have little effect on the recovery of the Scandinavian wolf population. Heterogenic infection patterns on the pack level in combination with the importance of individual-based factors (sex, pack size) and the north-south gradient for seroprevalence suggests low probability of wolf-to-wolf transmission of S. scabiei in Scandinavia.

Indexed as

AnimalsAntibodiesFemaleMaleSarcoptes scabieiScabiesScandinavian and Nordic CountriesSeroepidemiologic StudiesSex FactorsWolvesAntibodiesCanis lupusEctoparasitesELISAGrey wolfRed foxSarcoptes scabieiSarcoptic mangeVulpes vulpesWildlife disease

Identifiers

PMID27459965
PMCPMC4962404
OpenAlexW2487545491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.